Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.10.0.1
Segment Information (Tables)
3 Months Ended
Dec. 30, 2018
Segment Reporting [Abstract]  
Revenues, EBT and total assets for reportable segments
The table below presents revenues, EBT and total assets for reportable segments (in millions):
 
Three Months Ended
 
December 30,
2018
 
December 24,
2017
Revenues
 
 
 
QCT
$
3,739

 
$
4,651

QTL
1,018

 
1,266

QSI
27

 
30

Reconciling items
58

 
88

Total
$
4,842

 
$
6,035

EBT
 
 
 
QCT
$
598

 
$
955

QTL
590

 
854

QSI
8

 
11

Reconciling items
(637
)
 
(1,880
)
Total
$
559

 
$
(60
)
 
 
 
 

 
December 30,
2018
 
September 30,
2018
Assets
 
 
 
QCT
$
2,684

 
$
3,041

QTL
2,405

 
1,472

QSI
1,296

 
1,279

Reconciling items
27,861

 
26,926

Total
$
34,246

 
$
32,718


Reconciling items for reportable segments - revenues
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
 
Three Months Ended
 
December 30,
2018
 
December 24,
2017
Revenues
 
 
 
Nonreportable segments
$
58

 
$
88

 
$
58

 
$
88

EBT
 
 
 
Unallocated cost of revenues
$
(114
)
 
$
(117
)
Unallocated research and development expenses
(147
)
 
(280
)
Unallocated selling, general and administrative expenses
(64
)
 
(161
)
Unallocated other expenses (Note 2)
(149
)
 
(1,183
)
Unallocated interest expense
(153
)
 
(170
)
Unallocated investment and other income, net
20

 
124

Nonreportable segments
(30
)
 
(93
)
 
$
(637
)
 
$
(1,880
)
Reconciling items for reportable segments - EBT
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
 
Three Months Ended
 
December 30,
2018
 
December 24,
2017
Revenues
 
 
 
Nonreportable segments
$
58

 
$
88

 
$
58

 
$
88

EBT
 
 
 
Unallocated cost of revenues
$
(114
)
 
$
(117
)
Unallocated research and development expenses
(147
)
 
(280
)
Unallocated selling, general and administrative expenses
(64
)
 
(161
)
Unallocated other expenses (Note 2)
(149
)
 
(1,183
)
Unallocated interest expense
(153
)
 
(170
)
Unallocated investment and other income, net
20

 
124

Nonreportable segments
(30
)
 
(93
)
 
$
(637
)
 
$
(1,880
)
Unallocated acquisition-related expenses were comprised as follows (in millions):
 
Three Months Ended
 
December 30,
2018
 
December 24,
2017
Cost of revenues
$
103

 
$
106

Research and development expenses
1

 
2

Selling, general and administrative expenses
7

 
76